Ignite Creation Date:
2025-12-24 @ 11:29 PM
Ignite Modification Date:
2026-01-03 @ 11:39 PM
Study NCT ID:
NCT01985256
Status:
COMPLETED
Last Update Posted:
2018-05-21
First Post:
2013-11-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Sponsor:
Tocagen Inc.
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | glioma | View |
| None | glioblastoma | View |
| None | glioblastoma multiforme | View |
| None | Grade IV astrocytoma | View |
| None | brain cancer | View |
| None | recurrent glioblastoma | View |
| None | GBM | View |
| None | AA | View |
| None | AOD | View |
| None | anaplastic astrocytoma | View |
| None | anaplastic oligodendroglioma | View |
| None | anaplastic oligoastrocytoma | View |
| None | malignant glioma | View |
| None | high grade glioma | View |